S&P 500   4,563.59 (+0.29%)
DOW   35,491.79 (+0.45%)
QQQ   390.36 (+0.31%)
AAPL   190.78 (+0.52%)
MSFT   382.36 (+0.99%)
META   336.30 (+0.48%)
GOOGL   136.69 (+0.21%)
AMZN   147.22 (-0.35%)
TSLA   241.85 (+2.44%)
NVDA   480.23 (-0.45%)
NIO   7.24 (+0.70%)
BABA   76.14 (-1.79%)
AMD   122.13 (-0.42%)
T   16.16 (-0.31%)
F   10.39 (+0.48%)
MU   75.53 (-2.55%)
CGC   0.53 (-2.45%)
GE   119.67 (-0.25%)
DIS   94.14 (-1.08%)
AMC   6.70 (-1.47%)
PFE   29.96 (-0.60%)
PYPL   57.48 (+1.93%)
XOM   104.81 (+0.82%)
S&P 500   4,563.59 (+0.29%)
DOW   35,491.79 (+0.45%)
QQQ   390.36 (+0.31%)
AAPL   190.78 (+0.52%)
MSFT   382.36 (+0.99%)
META   336.30 (+0.48%)
GOOGL   136.69 (+0.21%)
AMZN   147.22 (-0.35%)
TSLA   241.85 (+2.44%)
NVDA   480.23 (-0.45%)
NIO   7.24 (+0.70%)
BABA   76.14 (-1.79%)
AMD   122.13 (-0.42%)
T   16.16 (-0.31%)
F   10.39 (+0.48%)
MU   75.53 (-2.55%)
CGC   0.53 (-2.45%)
GE   119.67 (-0.25%)
DIS   94.14 (-1.08%)
AMC   6.70 (-1.47%)
PFE   29.96 (-0.60%)
PYPL   57.48 (+1.93%)
XOM   104.81 (+0.82%)
S&P 500   4,563.59 (+0.29%)
DOW   35,491.79 (+0.45%)
QQQ   390.36 (+0.31%)
AAPL   190.78 (+0.52%)
MSFT   382.36 (+0.99%)
META   336.30 (+0.48%)
GOOGL   136.69 (+0.21%)
AMZN   147.22 (-0.35%)
TSLA   241.85 (+2.44%)
NVDA   480.23 (-0.45%)
NIO   7.24 (+0.70%)
BABA   76.14 (-1.79%)
AMD   122.13 (-0.42%)
T   16.16 (-0.31%)
F   10.39 (+0.48%)
MU   75.53 (-2.55%)
CGC   0.53 (-2.45%)
GE   119.67 (-0.25%)
DIS   94.14 (-1.08%)
AMC   6.70 (-1.47%)
PFE   29.96 (-0.60%)
PYPL   57.48 (+1.93%)
XOM   104.81 (+0.82%)
S&P 500   4,563.59 (+0.29%)
DOW   35,491.79 (+0.45%)
QQQ   390.36 (+0.31%)
AAPL   190.78 (+0.52%)
MSFT   382.36 (+0.99%)
META   336.30 (+0.48%)
GOOGL   136.69 (+0.21%)
AMZN   147.22 (-0.35%)
TSLA   241.85 (+2.44%)
NVDA   480.23 (-0.45%)
NIO   7.24 (+0.70%)
BABA   76.14 (-1.79%)
AMD   122.13 (-0.42%)
T   16.16 (-0.31%)
F   10.39 (+0.48%)
MU   75.53 (-2.55%)
CGC   0.53 (-2.45%)
GE   119.67 (-0.25%)
DIS   94.14 (-1.08%)
AMC   6.70 (-1.47%)
PFE   29.96 (-0.60%)
PYPL   57.48 (+1.93%)
XOM   104.81 (+0.82%)

Intelligent Bio Solutions Stock Price, News & Analysis (NASDAQ:INBS)

$0.28
-0.03 (-10.37%)
(As of 12:04 PM ET)
Compare
Today's Range
$0.27
$0.30
50-Day Range
$0.21
$1.34
52-Week Range
$0.20
$32.00
Volume
669,767 shs
Average Volume
1.74 million shs
Market Capitalization
$2.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Intelligent Bio Solutions MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
8.47% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.92mentions of Intelligent Bio Solutions in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$192 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($1.67) to ($0.47) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.76 out of 5 stars


INBS stock logo

About Intelligent Bio Solutions Stock (NASDAQ:INBS)

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

INBS Stock Price History

INBS Stock News Headlines

Intelligent Bio Solutions Inc. (INBS)
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
INBS: New Zealand & American Expansion
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
INBS: Australia Off to a Strong Start
See More Headlines
Receive INBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/08/2023
Today
11/28/2023
Next Earnings (Estimated)
2/13/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:INBS
Fax
N/A
Employees
51
Year Founded
N/A

Profitability

Net Income
$-10,630,000.00
Net Margins
-510.29%
Pretax Margin
-511.76%

Debt

Sales & Book Value

Annual Sales
$1.26 million
Book Value
$1.58 per share

Miscellaneous

Free Float
8,710,000
Market Cap
$2.68 million
Optionable
Not Optionable
Beta
4.03
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Harry Simeonidis (Age 56)
    President & CEO
    Comp: $310.79k
  • Mr. Spiro Kevin Sakiris B.Bus (Age 61)
    C.A., CA, Dip Law, Chief Financial Officer
    Comp: $274.43k
  • Ms. Victoria Gavrilenko (Age 40)
    Operations Manager
    Comp: $45k
  • Mr. Alex Arzeno
    VP of Investor Relations














INBS Stock Analysis - Frequently Asked Questions

How have INBS shares performed in 2023?

Intelligent Bio Solutions' stock was trading at $3.9980 at the start of the year. Since then, INBS stock has decreased by 93.1% and is now trading at $0.2750.
View the best growth stocks for 2023 here
.

When is Intelligent Bio Solutions' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 13th 2024.
View our INBS earnings forecast
.

How were Intelligent Bio Solutions' earnings last quarter?

Intelligent Bio Solutions Inc. (NASDAQ:INBS) released its quarterly earnings data on Wednesday, November, 8th. The company reported ($1.04) EPS for the quarter. The business earned $0.80 million during the quarter. Intelligent Bio Solutions had a negative trailing twelve-month return on equity of 147.23% and a negative net margin of 510.29%.

When did Intelligent Bio Solutions' stock split?

Intelligent Bio Solutions's stock reverse split on Friday, February 10th 2023. The 1-20 reverse split was announced on Friday, February 10th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 10th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of Intelligent Bio Solutions?

Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:INBS) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -